Skip to main navigation
Skip to Content
Terns Pharmaceuticals
  • About Us
    • Leadership
    • Board of Directors
  • Our Approach
    • Our Approach
    • Scientific Publications
  • Pipeline
    • Pipeline
    • Our Programs
    • Expanded Access
  • Investors & Media
    • Overview
    • Press Releases
    • Events and Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Email Alerts
  • Partnerships
  • Careers

Press Releases

01.4.24
Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference
01.3.24
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
  • Email Alerts
  • RSS Feeds
  • Print Page
  • Contact IR
Terns Logo
TERNS
1065 East Hillsdale Blvd., Suite 100
Foster City, CA 94404 (MAP)
info@ternspharma.com
investors@ternspharma.com
media@ternspharma.com
Phone: +1 650-525-5535 Ext.101
Fax: +1 650-275-4254
  • LinkedIn
  • Twitter
  • About Us
  • Our Approach
  • Pipeline
  • Investors & Media
  • Partnerships
  • Careers
  • Contact Us
© 2024 Terns Pharmaceuticals, Inc. Privacy Policy